Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.61 |
| ▸ | NPY1R | P25929 | 9/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.61 |
| ▸ | NPY2R | P49146 | 5/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7645663 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30866922 | 0.92 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29531604 | 0.92 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RGNPAT | |
| SCHEMBL10940118 | 0.91 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RGNPAT | |
| SCHEMBL29666714 | 0.91 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RGNPAT | |
| SCHEMBL24059390 | 0.91 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RGNPAT | |
| SCHEMBL1727152 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1940080 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1727150 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL4048021 | 0.90 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3414 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117230048-A | Threonine aldolase mutant with improved stereoselectivity and application thereof | 浙江工业大学 | 2023-12-15 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-116410307-B | Neutralizing antibody for neutralizing SARS-CoV-2 in six strains and its application | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-116262912-B | Hydroxylase mutant and application thereof | Center for excellence and innovation in molecular plant science, Chinese Academy of Sciences (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-106987570-B | Cas9 nuclease R780A and application thereof | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-113583116-B | Antibodies against SARS-CoV-1 or SARS-CoV-2 and uses thereof | 养生堂有限公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-116262135-B | Anti-CD 27 antibody compositions and uses thereof | 泰泽惠康生物医药有限责任公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-116262788-B | Anti-CD 27 antibody molecules | 泰泽惠康生物医药有限责任公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-112752837-B | Natural killer cells | 帝国理工学院创新有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-116583298-B | PD-1 targeted IL-15/IL-15RαFC fusion proteins with improved properties | 基因泰克公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-113993543-A | Combination therapy with anti-CD 38 antibodies | 武田药品工业株式会社 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993989-A | Process for producing ergothioneine | 丹麦科技大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113980880-A | Genetically engineered bacterium, application thereof and method for producing psicose by taking glucose as raw material | 吉林中粮生化有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-111849930-B | Mi-2 recombinant antigen and preparation method and application thereof | 珠海丽珠试剂股份有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-107429255-B | Methods for introducing multiple expression constructs into eukaryotic cells | 诺维信公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |
| WO-2001055713-A9 | METHOD AND APPARATUS FOR SEPARATING POLYNUCLEOTIDES USING MONOLITHIC CAPILLARY COLUMNS | TRANSGENOMIC INC (US) | 2002-10-31 | — | — | WO | disclosed |
| EP-1235852-A2 | METHOD AND APPARATUS FOR SEPARATING POLYNUCLEOTIDES USING MONOLITHIC CAPILLARY COLUMNS | TRANSGENOMIC, Inc. (US) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001055713-A2 | METHOD AND APPARATUS FOR SEPARATING POLYNUCLEOTIDES USING MONOLITHIC CAPILLARY COLUMNS | TRANSGENOMIC, INC. (US) | 2001-08-02 | — | — | WO | disclosed |